Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome | Colorectal Cancer | JAMA Oncology | JAMA Network

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome | Colorectal Cancer | JAMA Oncology | JAMA Network

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome

Kyle Chang, BSc^1,2; Melissa W. Taggart, MD³; Laura Reyes-Uribe, MD¹; et alEster Borras, PhD¹; Erick Riquelme, PhD¹; Reagan M. Barnett, PhD¹; Guido Leoni, PhD⁴; F. Anthony San Lucas, PhD⁵; Maria T. Catanese, PhD⁴; Federica Mori, BSc⁶; Maria G. Diodoro, MD⁷; Y. Nancy You, MD, MHSc^8,9; Ernest T. Hawk, MD, MPH¹; Jason Roszik, PhD, MBA^10,11; Paul Scheet, PhD^2,5; Scott Kopetz, MD, PhD¹²; Alfredo Nicosia, PhD^4,13,14; Elisa Scarselli, MD⁴; Patrick M. Lynch, MD, JD^9,15; Florencia McAllister, MD^1,2,9,12; Eduardo Vilar, MD, PhD^1,2,9,12

Author Affiliations Article Information

JAMA Oncol. Published online April 16, 2018. doi:10.1001/jamaoncol.2018.1482